Potentially repurposable drugs for schizophrenia identified from its interactome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potentially repurposable drugs for schizophrenia identified from its interactome

Published:2019-09-03 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Karunakaran Kalyani B.,Chaparala Srilakshmi,Ganapathiraju Madhavi K.

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-48307-w.pdf

Reference97 articles.

1. Corvin, A. P. Two patients walk into a clinic…a genomics perspective on the future of schizophrenia. BMC biology 9, 77, https://doi.org/10.1186/1741-7007-9-771741-7007-9-77 (2011).

2. Farrell, M. S. et al. Evaluating historical candidate genes for schizophrenia. Molecular psychiatry. https://doi.org/10.1038/mp.2015.16 (2015).

3. Ganapathiraju, M. K. et al. Schizophrenia interactome with 504 novel protein-protein interactions. NPJ Schizophr 2, 16012, https://doi.org/10.1038/npjschz.2016.12 (2016).

4. Thomas, D. W. et al. Clinical development success rates 2006–2015. San Diego: Biomedtracker/Washington, DC: BIO/Bend: Amplion (2016).

5. Athauda, D. et al. Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. The Lancet 390, 1664–1675 (2017).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schizophrenia interactome derived repurposable drugs and randomized control trials of two candidates;Biological Psychiatry;2024-06

2. Malignant peritoneal mesothelioma interactome with 417 novel protein–protein interactions;BJC Reports;2024-05-24

3. Network-based drug repurposing for schizophrenia;Neuropsychopharmacology;2024-02-06

4. Computational Techniques for Drug Repurposing: A Paradigm Shift in Drug Discovery;Current Drug Therapy;2023-08

5. Unveiling causal regulatory mechanisms through cell-state parallax;2023-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3